EUVIMEDEUVIMED entdecken
Crossref

Effectiveness of a Regionalized Care Model in Treating Fournier’s Gangrene

Sai Allu, Kamil Malshy iD, Borivoj Golijanin, Martus Gn, Emma Waddell, John Morgan, Benjamin Ahn, Amir Farah iD, Rebecca Ortiz, Raymond Che iD, Kennon Miller, Madeline Cancian

The American Surgeon™ · 2025

DOI: 10.1177/00031348251331287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Surgeon™, 2025. Verfasst von Sai Allu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Warren Alpert Medical School of Brown University, Providence, RI, USA. Hauptthemen laut MEDLINE: Fournier Gangrene, Patient Transfer. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the impact of transferring patients with Fournier's gangrene (FG) to a tertiary referral hospital (TRH) on survival and outcomes.

Methods

We conducted a retrospective analysis of FG cases treated at our TRH from January 2015 to January 2022. Clinicodemographic, laboratory, perioperative, and mortality data were collected. Patients were categorized into two groups: those directly presented (DP) to TRH and those transferred for treatment (TT) from other hospitals. Primary outcome was 30-day mortality. Secondary outcomes included 90-day, 180-day, 1-year and 2-year mortality. We employed chi-square, T-tests, and Fisher's exact tests for significance assessment. Survival was evaluated using Kaplan-Meier.

Results

136 patients (77.9% males) were analyzed: 66.9% in the TT group (n = 91), 33.1% in DP group (n = 45), with median ages of 59.2 and 56.4, respectively, P = 0.06. Median transfer distance: 10.6 miles, travel time: 16 minutes. No significant differences were observed in time from presentation to initial debridement (8.45 hours for TT, 7.3 hours for DP, P = 0.57), comorbidities, or FG Severity Index. No significant differences in 30-day mortality (TT: 5.5%, DP: 4.4%, [HR = 1.53, 95% CI: 0.31, 7.57], P = 0.6), or other mortality rates (90-day: 7.7% vs 6.6%, 180-day: 14.3% vs 8.9%, 1-year: 18.7% vs 15.6%, 2-year: 20.9% vs 15.6%, P > 0.05). DP had a higher rate of fast door-to-operation room (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fournier GangrenePatient TransferHumansMaleRetrospective StudiesMiddle AgedFemaleDebridementAgedTertiary Care CentersTreatment OutcomeAdult

Stichwörter der Autor:innen

FGdebridementemergencyfournier’s gangrenemortalityoutcomesurvivaltransfer

Autor:innen und Institutionen

  • Warren Alpert Medical School of Brown University, Providence, RI, USA.
  • The Minimally Invasive Urology Institute, The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.
  • Department of Surgery, Medical College of Wisconsin, Milwaukee, USA.

ORCID-Profile: Kamil Malshy, Amir Farah, Raymond Che

Zitieren

APA

Allu, S., Malshy, K., Golijanin, B., Gn, M., Waddell, E., Morgan, J., Ahn, B., Farah, A., Ortiz, R., Che, R., Miller, K., & Cancian, M. (2025). Effectiveness of a Regionalized Care Model in Treating Fournier’s Gangrene. The American Surgeon™. https://doi.org/10.1177/00031348251331287

Vancouver

Allu S, Malshy K, Golijanin B, Gn M, Waddell E, Morgan J, et al. Effectiveness of a Regionalized Care Model in Treating Fournier’s Gangrene. The American Surgeon™. 2025. doi:10.1177/00031348251331287

BibTeX
@article{Allu2025,
  author = {Allu, Sai and Malshy, Kamil and Golijanin, Borivoj and Gn, Martus and Waddell, Emma and Morgan, John and Ahn, Benjamin and Farah, Amir and Ortiz, Rebecca and Che, Raymond and Miller, Kennon and Cancian, Madeline},
  title = {Effectiveness of a Regionalized Care Model in Treating Fournier’s Gangrene},
  journal = {The American Surgeon™},
  year = {2025},
  doi = {10.1177/00031348251331287}
}
Kostenlos starten →